Navigation Links
Research by Case Western Reserve University, VA earns cover of prestigious science publication
Date:1/4/2008

CLEVELAND An interdisciplinary team from the department of macromolecular science and engineering at Case Western Reserve University, the Louis Stokes Cleveland VA Medical Center and the NASA Glenn Research Center earned the December 2007 cover of Nature Nanotechnology, one of the worlds most prestigious scholarly journals covering research in nanoscience and nanotechnology.

Jeffrey R. Capadona, associate investigator at the VAs Advanced Platform Technology (APT) Center and Christoph Weder and Stuart Rowan, professors of macromolecular science and engineering at the Case School of Engineering and their colleagues have unveiled a method for developing mechanically-reinforced polymer nanocomposites.

The incorporation of nanoparticles into polymers is a design approach that is used in all areas of materials science, says Weder, who is the senior author of the paper, adding that in the past, the broad technological utilization of polymer nanocomposites has been stifled by a lack of effective methods to control nanoparticle dispersion in materials.

In their new approach, the team used a process in which the reinforcing nanoparticles are first assembled into a three-dimensional network through gelation of nanoparticle dispersion, essentially forming a template. This template can then be filled with any polymer of choice by exchanging the solvent with a polymer-containing solution.

Through the use of this new technique, we have been able to take the most incompatible components and show that they can be used to make compatible materials, Weder said.

While the research primarily focused on cellulose whiskers as the choice of nanoparticles since they offer useful mechanical properties and are readily obtained from renewable biosources such as wood and cotton, Capadona explained, the team also started to investigate an array of different polymers and nanofibers, demonstrating that the technique has broad applicability.


'/>"/>

Contact: Laura M. Massie
laura.massie@case.edu
216-368-4442
Case Western Reserve University
Source:Eurekalert

Page: 1

Related biology technology :

1. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
2. Ames Laboratory researchers solve fuel-cell membrane structure conundrum
3. Clemson researcher studies carbon fibers for nuclear reactor safety
4. Professor Straufs research is Nature Photonics’ cover article
5. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
6. 49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases
7. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
8. Binex and MaxCyte Collaborate on Cancer Immunotherapy Research
9. Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
10. Center for Molecular Medicine Offers Xceed Ziplex(TM) Services to Research Community
11. eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...Nov. 5 SpineSmith Partners has sig...-develop a unique scaffold that mimics the structu...on of several commercial products by SpineSmith,s ...elieves the GenOsteo scaffold represents a signifi...ue and ideal environment for the delivery of adult...
(Date:11/5/2009)... LASIK Surgery and vision correction experts l... actively involved at the recently concluded Ameri...ting in San Francisco, California. Dr. Stephen Bri...n Davidorf, MD, Dr. Peter Rapoza, MD, Dr. Michael ...Bowman, MD, Dr. Edward Manche, MD, and Dr. Parag M...
(Date:11/4/2009)... The Human Anthrax Vaccine Program must be sto...feature film "A Call to Arms:2009 Edition&quo...atal Immunity: The Human Anthrax Vaccine Story&quo...t danger of top secret government science turned i...untability to its victims. It is available for wo...
(Date:11/4/2009)...ILLE, Md., Nov. 4 Zyngenia, Inc., ...n next-generation antibody drug development, today...es A funding from New Enterprise Associates (NEA),... The capital will be used to create novel, multi-s...r more biological targets with a single agent. The...
Breaking Biology Technology:SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
... PAREXEL International,Corporation (Nasdaq: PRXL ...anization, today announced the successful completi...tional Clinical Research Co., Ltd. ("APEX") in,a s...uisition and other,factors discussed herein, the C...uidance for the first quarter of Fiscal Year 2008 ...
... Sept. 26 InterMune, Inc.,(Nasdaq: ITMN ) today ...025,000 shares of common stock at a price to the p...s of common stock, representing the exercise,by th...nal shares in the,offering. The net proceeds to th...million, after payment of underwriting discounts a...
...., Sept. 26 Corium International,Inc., a privatel...nounced,that it has completed a $25.1 million Seri...res. Quantum Technology Partners, Aphelion Capital... round. In connection with,the financing, StrataGe...Ventures portfolio company focused on needle-free ...
Other Biology Technology:PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 2PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 3PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 4InterMune Announces Closing of Public Offering of Common Stock 2Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 2Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 3Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 4
(Date:11/6/2009)... Center and the Chinese Academy of Sciences (CAS) ...on Taste and Smell Research. Organized by Monell i...the first international meeting on taste and smell...utive Officer, American Association for the Advanc...e magazine, will open the meeting with a plenary a...
(Date:11/5/2009)...ty have developed synthetic molecules capable of e...-infected cells, as well as to prostate cancer cel...al of the American Chemical Society , could lead t... , The molecules called "antibody-recruiting m...iting molecule targeting prostate cancer" (ARM-P) ...
(Date:11/4/2009)...ant to officially endorse green tea as a cancer pr...its protective effects, including results of a new...a journal of the American Association for Cancer R...cer. , Vassiliki Papadimitrakopoulo, M.D., prof...ad and Neck Medical Oncology at the University of ...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2UNC scientists garner new NIH awards for high risk transformative research 10076 1UNC scientists garner new NIH awards for high risk transformative research 10076 2UNC scientists garner new NIH awards for high risk transformative research 10076 3UNC scientists garner new NIH awards for high risk transformative research 10076 4Thomson Reuters Predicts Nobel Laureates 14245 1Thomson Reuters Predicts Nobel Laureates 14245 2Thomson Reuters Predicts Nobel Laureates 14245 3Thomson Reuters Predicts Nobel Laureates 14245 4Thomson Reuters Predicts Nobel Laureates 14245 5Thomson Reuters Predicts Nobel Laureates 14245 6RetireSafe to Senate 3A Stop Proposed Rationing of High Quality Hospital Care Medicare Needs More Physician Hospitals 58219 1RetireSafe to Senate 3A Stop Proposed Rationing of High Quality Hospital Care Medicare Needs More Physician Hospitals 58219 2
.... A hypertension medication called olmesartan med...the arteries that occurs in patients with high blo... Ferrario, M.D., one of the study,s lead investiga... Research Center at Wake Forest University Baptist... the growing evidence for the role of angiotensin ...
...he Smithsonian,s National Zoo have performed the f...s horse ( E. ferus przewalskii ; E. caballus prze...-VAL-skeez. Przewalksi,s horses are a horse specie...xtinct in the wild in 1970. Currently, there are a...oological institutions throughout the world and in...
...nce and technology policymaking capacity of the Wh...ent can better address key issues facing the natio...rity, and the ability of the United States to comp...primary recommendations are that: , The next P...ader to be Assistant for Science and Technology Po...
Other Biology News:Hypertension treatment effective in reversing vascular damage 2First successful reverse vasectomy on endangered species performed at the National Zoo 2First successful reverse vasectomy on endangered species performed at the National Zoo 3White House science office needs upgrade 2White House science office needs upgrade 3
Human SLPI ELISA Kit from R&D Systems
Rabbit Anti-Human OLFM1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
GELase 50X Reaction Buffer from EPICENTRE Biotechnologies
Axl, phospho ELISA development Kit, DuoSet IC Economy Pack from R&D Systems
Biology Products: